Dean, Olivia M.

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 1,178

A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial)

Jacka, F. N., O’Neil, A., Opie, R., Itsiopoulos, C., Cotton, S., Mohebbi, M., Castle, D., Dash, S., Mihalopoulos, C., Chatterton, M. L., et al. (2017) · BMC Medicine

Nutritional Studies and DietTreatment of Major Depression

Cited by 1,093

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology

Antioxidant Activity and Oxidative StressTryptophan and brain disorders

Cited by 1,069

The chemistry and biological activities of N-acetylcysteine

Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects

Sulfur Compounds in BiologyRedox biology and oxidative stress

Cited by 876

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry

Schizophrenia research and treatmentAmino Acid Enzymes and Metabolism

Cited by 552

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 500

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 494

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews

Sulfur Compounds in BiologyTreatment of Major Depression

Cited by 463

The promise of N-acetylcysteine in neuropsychiatry

Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences

Sulfur Compounds in BiologyTreatment of Major Depression

Cited by 434

N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility

Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy

Drug-Induced Hepatotoxicity and ProtectionSulfur Compounds in Biology

Cited by 413

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

Fernandes, B. S., Steiner, J., Bernstein, H.-G., Dodd, S., Pasco, J. A., Dean, O. M., Nardin, P., Gonçalves, C.-A., & Berk, M. (2016) · Molecular Psychiatry

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 348

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 336

Glutathione: a novel treatment target in psychiatry

Berk, M., Ng, F., Dean, O., Dodd, S., & Bush, A. I. (2008) · Trends in Pharmacological Sciences

Sulfur Compounds in BiologyRedox biology and oxidative stress

Cited by 183

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

Berk, M., Dean, O., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Allwang, C., et al. (2011) · Journal of Affective Disorders

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 181

The Efficacy of Adjunctive N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 172

A model of the mitochondrial basis of bipolar disorder

Morris, G., Walder, K., McGee, S. L., Dean, O. M., Tye, S. J., Maes, M., & Berk, M. (2017) · Neuroscience & Biobehavioral Reviews

Bipolar Disorder and TreatmentMitochondrial Function and Pathology

Cited by 162

Minocycline: Therapeutic Potential in Psychiatry

Dean, O. M., Data-Franco, J., Giorlando, F., & Berk, M. (2012) · CNS Drugs

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 131

N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review

Oliver, G., Dean, O., Camfield, D., Blair-West, S., Ng, C., Berk, M., & Sarris, J. (2015) · Clinical Psychopharmacology and Neuroscience

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 96

Prebiotics, probiotics, fermented foods and cognitive outcomes: a meta-analysis of randomized controlled trials

Marx, W., Scholey, A., Firth, J., D’Cunha, N. M., Lane, M., Hockey, M., Ashton, M. M., Cryan, J. F., O’Neil, A., Naumovski, N., et al. (2020) · Neuroscience & Biobehavioral Reviews

Probiotics and Fermented FoodsMicrobial Metabolites in Food Biotechnology

Cited by 87

Tobacco use in bipolar disorder

Thomson, D., Berk, M., Dodd, S., Rapado-Castro, M., Quirk, S. E., Ellegaard, P. K., Berk, L., & Dean, O. M. (2015) · Clinical Psychopharmacology and Neuroscience

Smoking Behavior and CessationBipolar Disorder and Treatment

Cited by 63

Effects of N‐acetyl cysteine on cognitive function in bipolar disorder

Dean, O. M., Bush, A. I., Copolov, D. L., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2012) · Psychiatry and Clinical Neurosciences

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 58

A preliminary investigation on the efficacy of N -acetyl cysteine for mania or hypomania

Vieira da Silva Magalhães, P., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2013) · Australian & New Zealand Journal of Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 58

Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial

Dean, O. M., Maes, M., Ashton, M., Berk, L., Kanchanatawan, B., Sughondhabirom, A., Tangwongchai, S., Ng, C., Dowling, N., Malhi, G. S., et al. (2014) · Clinical Psychopharmacology and Neuroscience

Treatment of Major DepressionTryptophan and brain disorders

Cited by 58

Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology

Data-Franco, J., Singh, A., Popovic, D., Ashton, M., Berk, M., Vieta, E., Figueira, M. L., & Dean, O. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 38